Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis

Table 2 Pair-wise comparison of hemoglobin changes between 2 consecutive visits (n = 30)

Comparison	Hb change1	P value	Significance criteria
Week 0 vs Week 2	0.7 (0.2)	0.0003	0.0250
Week 2 vs Week 4	1.3 (0.2)	< 0.0001	0.0167
Week 4 vs Week 8	1.3 (0.2)	< 0.0001	0.0125
Week 8 vs Week 12	0.6 (0.2)	0.0060	0.0500

¹Data were presented as mean (standard error). P values and significance criteria presented were those after the pair-wise comparisons based on Bonferroni-Holm step-down adjustment. SE: Standard error; Hb: Hemoglobin.